Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.
|
| Abstract |
We report the structure-guided discovery, synthesis, and initial characterization of 3,5-diamino-piperidinyl triazines (DAPT), a novel translation inhibitor class that targets bacterial rRNA and exhibits broad-spectrum antibacterial activity. DAPT compounds were designed as structural mimetics of aminoglycoside antibiotics which bind to the bacterial ribosomal decoding site and thereby interfere with translational fidelity. We found that DAPT compounds bind to oligonucleotide models of decoding-site RNA, inhibit translation in vitro, and induce translation misincorporation in vivo, in agreement with a mechanism of action at the ribosomal decoding site. The novel DAPT antibacterials inhibit growth of gram-positive and gram-negative bacteria, including the respiratory pathogen Pseudomonas aeruginosa, and display low toxicity to human cell lines. In a mouse protection model, an advanced DAPT compound demonstrated efficacy against an Escherichia coli infection at a 50% protective dose of 2.4 mg/kg of body weight by single-dose intravenous administration.
|
|---|---|
| Authors | Yuefen Zhou, Vlad E Gregor, Zhongxiang Sun, Benjamin K Ayida, Geoffrey C Winters, Douglas Murphy, Klaus B Simonsen, Dionisios Vourloumis, Sarah Fish, Jamie M Froelich, Daniel Wall, Thomas Hermann |
| Journal | Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 49 Issue 12 Pg. 4942-9 (Dec 2005) ISSN: 0066-4804 [Print] United States |
| PMID | 16304156 (Publication Type: Journal Article, Research Support, N.I.H., Extramural) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!